Study Reveals Advantages of Non-Calcareous Phosphate Binders
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
Calciphylaxis was 75% less likely to develop in patients who received the drug rather than placebo.
Researchers in the Netherlands report results from an autopsy study of diabetic nephropathy patients.
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension in acute kidney injury (AKI).
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.